# Ultima Genomics

Source: https://onco.cc/companies/ultima-genomics/  
OnCo record `ultima-genomics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Open-wafer sequencing (UG 100) claiming a $100 genome, aimed at population-scale and deep ctDNA sequencing.

## Summary

Ultima Genomics, based in Fremont, California, makes the UG 100 open-wafer sequencer, marketed on the claim of a 100 dollar genome and aimed at population-scale and deep circulating tumour DNA sequencing. It launched commercially in 2024, is used by Exact Sciences and others for high-depth cell-free DNA, and raised more than 600 million dollars in 2022 with further rounds since. OnCo links it to new short-read sequencing platforms. Whether cheaper sequencing at depth makes blood-based cancer detection and residual disease testing affordable at population scale is the open question. The short-read platforms page carries the wider picture.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Fremont, CA
- Type: diagnostics
- Website: https://www.ultimagenomics.com

## Sources

- Official website: https://www.ultimagenomics.com

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [New short-read sequencing platforms](https://onco.cc/technologies/next-gen-short-read-platforms/)

---
JSON: https://onco.cc/api/v1/entities/ultima-genomics.json